Who owns INHIBIKASE THERAPEUTICS INC?
- Ticker: IKT
- CUSIP Number: 45719w205
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibikase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibikase Therapeutics stock
Who bought or sold INHIBIKASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sands Capital Ventures | 11M | $18M | 0% | Sep 2025 |
|
| Soleus Capital Management | 6.3M | $10M | 0% | Sep 2025 |
|
| Fairmount Funds Management | 6.1M | $9.9M | 0% | Sep 2025 |
|
| Perceptive Advisors | 5.4M | $8.8M | 0% | Sep 2025 |
|
| Commodore Capital | 5.4M | $8.7M | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 5.2M | $8.5M | 2% | Sep 2025 |
|
| Vanguard Group | 3.3M | $5.3M | 2% | Sep 2025 |
|
| BlackRock | 3.1M | $5.0M | 13% | Sep 2025 |
|
| Blackstone Group | 2.6M | $4.3M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 2.2M | $3.5M | 0% | Sep 2025 |
|
| Geode Capital Management | 1.1M | $1.8M | 4% | Sep 2025 |
|
| Stonepine Capital Management | 735k | $1.2M | 0% | Sep 2025 |
|
| State Street Corporation | 508k | $823k | 28% | Sep 2025 |
|
| Northern Trust | 374k | $606k | -5% | Sep 2025 |
|
| William Blair $ Company | 153k | $248k | -3% | Sep 2025 |
|
| Charles Schwab Investment Management | 152k | $247k | 0% | Sep 2025 |
|
| Bank of New York Mellon | 139k | $225k | 5% | Sep 2025 |
|
| UBS Group | 136k | $221k | 252% | Sep 2025 |
|
| FMR | 106k | $171k | -27% | Sep 2025 |
|
| Morgan Stanley | 100k | $194k | 100% | Jun 2025 |
|
| Barclays | 86k | $139k | -22% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 81k | $130k | 100% | Sep 2025 |
|
| Nuveen | 79k | $127k | 0% | Sep 2025 |
|
| Citadel Advisors | 72k | $116k | 100% | Sep 2025 |
|
| Rhumbline Advisers | 58k | $93k | -2% | Sep 2025 |
|
| Jpmorgan Chase & Co | 50k | $81k | 100% | Sep 2025 |
|
| New York State Common Retirement Fund | 48k | $78k | -21% | Sep 2025 |
|
| Wells Fargo & Company | 46k | $74k | 19% | Sep 2025 |
|
| Susquehanna International | 46k | $74k | -88% | Sep 2025 |
|
| Invesco | 33k | $54k | 8% | Sep 2025 |
|
| Intech Investment Management | 32k | $52k | 2% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 28k | $45k | -15% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 18k | $29k | 100% | Sep 2025 |
|
| Caxton | 16k | $27k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 16k | $25k | 70% | Sep 2025 |
|
| Virtu Financial | 13k | $22k | 100% | Sep 2025 |
|
| Ing Investment Management | 13k | $21k | -30% | Sep 2025 |
|
| Goldman Sachs Group | 11k | $17k | -94% | Sep 2025 |
|
| Buckingham Strategic Partners | 11k | $17k | 0% | Sep 2025 |
|
| ProShare Advisors | 10k | $17k | -17% | Sep 2025 |
|
| Russell Investments | 7.7k | $13k | 100% | Sep 2025 |
|
| Tower Research Capital | 7.0k | $11k | 6946% | Sep 2025 |
|
| Summit Investment Advisors | 6.2k | $10k | 0% | Sep 2025 |
|
| Legal & General Group | 5.5k | $8.9k | 0% | Sep 2025 |
|
| Sterling Capital Management | 3.8k | $6.2k | 154% | Sep 2025 |
|
| California State Teachers Retirement System | 3.8k | $6.1k | 0% | Sep 2025 |
|
| Amalgamated Bank | 2.1k | $3.0k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 663.00 | $1.0k | -86% | Sep 2025 |
|
| Pnc Financial Services | 90.00 | $145.998000 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 86.00 | $139.001800 | 100% | Sep 2025 |
|
| CWM | 19.00 | $0 | 100% | Sep 2025 |
|
Who sold out of Inhibikase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| LMR Partners | Jun 2025 | 31k | $61k |
| Raymond James Financial | Jun 2025 | 1.0k | $2.0k |